跳至主要内容
临床试验/NCT04974307
NCT04974307
终止
不适用

Pilot Study of an Optic-to-Audio Device in a Pediatric Cohort With CLN3-related Conditions or Low Vision

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1 个研究点 分布在 1 个国家目标入组 11 人2021年9月30日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
CLN3-related Disorders
发起方
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
入组人数
11
试验地点
1
主要终点
Participants With Adverse Events
状态
终止
最后更新
去年

概览

简要总结

Background:

CLN3 involves vision loss observed around the preschool years, with eventual progression to blindness within 1-3 years. Researchers want to test an assistive device that may help children with CLN3 or with non-CLN3 related blindness.

Objective:

To learn if it is safe, easy, and useful for children with CLN3 or with non-CLN3 related blindness to use the OrCam.

Eligibility:

People aged 6-18 years who have either CLN3-related disease or non-CLN3 related blindness.

Design:

Participants will be screened with the following:

Medical history

Physical exam

Family history

Eye exam and vision tests. They will get eyedrops to dilate their eyes.

Psychological and neurocognitive tests. They will be asked questions and observed for how they do various tasks, such as talking, playing, writing, drawing, and solving problems.

Hearing tests. They may wear headphones or earplugs. Electrodes may be taped to their head.

Blood samples

Skin biopsy, if needed

Cheek cell, saliva, or urine samples

The OrCam is the size of and weighs about half as much as a pack of gum. It is attached to eyeglass frames by magnets. Participants will do tasks before and after they have been trained on the OrCam. They will do these tasks without or with using the OrCam.

Participants will be given an OrCam to use for 1 week or 1 month. They will have check-in sessions with the study team.

Participants and/or their caregivers will be asked about abilities, behaviors, social skills, learning methods, intelligence, and health-related quality of life.

Participants samples may be used for genetic testing and/or to make a type of stem cell.

Participation will last for 1-5 weeks.

详细描述

Study Description: This is a pilot study of an augmentative visual device, OrCam MyEye 2 (OrCam), in pediatric individuals with CLN3-related conditions or low vision. We hypothesize that, given the relatively simple design and operating procedure of the device, the use of the OrCam by study participants will be safe and feasible. We also hypothesize that the device will enhance their ability to obtain visually based information. Objectives: Primary: Assess the safety and feasibility of OrCam use by children with CLN3 or low vision. Endpoints: Primary: 1. Adverse events during the use of OrCam 2. Feasibility test 3. Feasibility questionnaire The assessment periods will be 1 week at study site.

注册库
clinicaltrials.gov
开始日期
2021年9月30日
结束日期
2023年10月7日
最后更新
去年
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

发起方
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
责任方
Sponsor

入排标准

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Participants With Adverse Events

时间窗: 1 week

Number of participants with adverse events related to the use of OrCam MyEye 2. Adverse events were collected from parental report.

研究点 (1)

Loading locations...

相似试验